Loading...

Verano Holdings Corp.

VRNOF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.30
$0.10(8.33%)
U.S. Market opens in 14h 23m

Verano Holdings Corp. (VRNOF) Stock Overview

Explore Verano Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap470.4M
P/E Ratio-1.82
EPS (TTM)$-0.99
ROE-0.30%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$1.64
1 Year Target$0.00

VRNOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Verano Holdings Corp. (VRNOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.82 and a market capitalization of 470.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-20.25%
Year-to-Date (YTD) Change
3.17%
1-Year Change
140.74%
3-Year Change
-53.07%
5-Year Change
-92.88%
All-Time (Max) Change
-94.58%

Contact Information

https://www.verano.com
312 265 0730
415 North Dearborn Street, Chicago, IL, 60654

Company Facts

38,000 Employees
IPO DateFeb 18, 2021
CountryUS

Frequently Asked Questions